Stockysis — AI-Powered Stock News & Sentiment Analysis

Jones Trading Downgrades Day One Biopharmaceutical to Hold, Raises Price Target to $21.5

Benzinga Newsdesk www.benzinga.com Negative 59.5%

Neg 59.5% Neu 0% Pos 0%

Jones Trading analyst Soumit Roy downgrades Day One Biopharmaceutical (NASDAQ:DAWN) from Buy to Hold and raises the price target from $20 to $21.5.

Comments

No comments yet. Be the first!